DK2908871T3 - Fremgangsmåder til behandling af abscesser - Google Patents

Fremgangsmåder til behandling af abscesser Download PDF

Info

Publication number
DK2908871T3
DK2908871T3 DK13847381.4T DK13847381T DK2908871T3 DK 2908871 T3 DK2908871 T3 DK 2908871T3 DK 13847381 T DK13847381 T DK 13847381T DK 2908871 T3 DK2908871 T3 DK 2908871T3
Authority
DK
Denmark
Prior art keywords
fistula
therapeutic agent
abscess
solid matrix
abscess cavity
Prior art date
Application number
DK13847381.4T
Other languages
English (en)
Inventor
Allan B Dietz
Eric J Dozois
William A Faubion
Original Assignee
Mayo Found Medical Education & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Found Medical Education & Res filed Critical Mayo Found Medical Education & Res
Application granted granted Critical
Publication of DK2908871T3 publication Critical patent/DK2908871T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Materials For Medical Uses (AREA)

Claims (12)

1. Medicinsk anordning til anvendelse til behandling af en absceshule hos et pattedyr, hvilken anordning omfatter: (a) en stikprop, der omfatter en skivedel og flere ben, der er fastgjort til skivedelen, hvilken skivedel og hvilke ben er konfigureret til implantation i absceshulen, hvor skivedelen og benene er lavet af fast biokompatibelt matrixfyldmateriale, og (b) et terapeutisk middel, hvor det terapeutiske middel er bundet til det faste biokompatible matrixfyldmateriale.
2. Medicinsk anordning ifølge krav 1, hvor pattedyret er et menneske.
3. Medicinsk anordning ifølge krav 1 eller 2, hvor absceshulen er en fistel.
4. Medicinsk anordning ifølge et hvilket som helst af krav 1 til 3, hvor fistlen er en anal fistel.
5. Medicinsk anordning ifølge et hvilket som helst af krav 1 til 4, hvor det terapeutiske middel er a) et stamcellemateriale; eller b) et trombocytderivatmateriale.
6. Medicinsk anordning ifølge krav 5, hvor stamcellematerialet er fedtafledte stamceller, og de fedtafledte stamceller er absorberet i det faste biokompatible matrixfyldmateriale .
7. Fremgangsmåde til opnåelse af en medicinsk anordning til anvendelse til behandling af en absceshule hos et pattedyr, hvilken fremgangsmåde omfatter: (a) tilvejebringelse af en stikprop, der omfatter en skivedel og flere ben, der er fastgjort til skivedelen, hvilken skivedel og hvilke ben er konfigureret til implantation i absceshulen, hvor skivedelen og benene er lavet af fast biokompatibelt matrixfyldmateriale, (b) behandling af det faste biokompatible matrixfyldmateriale med et terapeutisk middel, hvor behandlingen mætter det faste biokompatible matrixfyldmateriale med det terapeutiske middel, og hvor det terapeutiske middel kan fremme heling af absceshulen.
8. Fremgangsmåde ifølge krav 7, hvor pattedyret er et menneske.
9. Fremgangsmåde ifølge krav 7 eller 8, hvor absceshulen er en fistel.
10. Fremgangsmåde ifølge et hvilket som helst af kravene 7 til 9, hvor fistlen er en anal fistel.
11. Fremgangsmåde ifølge et hvilket som helst af kravene 7 til 10, hvor det terapeutiske middel er a) et stamcellemateriale; eller b) et trombocytderivatmateriale.
12. Fremgangsmåde ifølge krav 11, hvor stamcellematerialet er fedtafledte stamceller, og de fedtafledte stamceller er absorberet i det faste biokompatible matrixfyldmateriale.
DK13847381.4T 2012-10-18 2013-10-18 Fremgangsmåder til behandling af abscesser DK2908871T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261715506P 2012-10-18 2012-10-18
PCT/US2013/065631 WO2014063022A1 (en) 2012-10-18 2013-10-18 Techniques for treatment of abscesses

Publications (1)

Publication Number Publication Date
DK2908871T3 true DK2908871T3 (da) 2018-12-03

Family

ID=50488779

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13847381.4T DK2908871T3 (da) 2012-10-18 2013-10-18 Fremgangsmåder til behandling af abscesser
DK18187769.7T DK3473276T3 (da) 2012-10-18 2013-10-18 Teknikker til behandling af abscesser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK18187769.7T DK3473276T3 (da) 2012-10-18 2013-10-18 Teknikker til behandling af abscesser

Country Status (6)

Country Link
US (2) US20150258249A1 (da)
EP (2) EP3473276B1 (da)
DK (2) DK2908871T3 (da)
ES (2) ES2968961T3 (da)
FI (1) FI3473276T3 (da)
WO (1) WO2014063022A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3051452A1 (en) * 2017-03-21 2018-09-27 Mayo Foundation For Medical Education And Research Methods and materials for treating fistulas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) * 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
CN101404942B (zh) * 2005-04-29 2013-11-20 库克生物科技公司 治疗瘘的立体移植物和相关系统
JP2008543504A (ja) * 2005-06-21 2008-12-04 クック・インコーポレイテッド 瘻孔を閉鎖する移植可能なグラフト
MX2009010387A (es) * 2007-03-26 2009-10-19 Baxter Int Relleno de vacio inyectable para el aumento de tejido blando.
US20110293666A1 (en) * 2007-11-28 2011-12-01 Xianyan Wang Bioengineered Tissue Constructs and Methods for Production and Use
US20110282368A1 (en) * 2010-05-12 2011-11-17 Swayze Jeffrey S Fistula Repair Device with Extendable Barbs and Therapeutic Cell Delivery
CA3051452A1 (en) * 2017-03-21 2018-09-27 Mayo Foundation For Medical Education And Research Methods and materials for treating fistulas

Also Published As

Publication number Publication date
DK3473276T3 (da) 2024-01-29
EP2908871B1 (en) 2018-08-08
EP3473276A1 (en) 2019-04-24
EP3473276B1 (en) 2023-12-13
EP2908871A4 (en) 2016-06-29
FI3473276T3 (fi) 2024-01-24
US20190001028A1 (en) 2019-01-03
US20150258249A1 (en) 2015-09-17
ES2968961T3 (es) 2024-05-14
ES2692290T3 (es) 2018-12-03
EP2908871A1 (en) 2015-08-26
WO2014063022A1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
US9456893B2 (en) Engineered tissue implants and methods of use thereof
CA2772375C (en) Methods and devices for cellular transplantation
ES2546734T3 (es) Preparación rápida y uso de tejidos y estructuras obtenidas por ingeniería tisular como implantes individuales
US10363343B2 (en) Tissue-based drain manifolds
JP6490869B2 (ja) 心筋組織再生用３次元構造体およびその製造方法
ES2908275T3 (es) Composiciones en polvo para generar espumas de proteínas reticuladas y métodos de uso de las mismas
ES2935163T3 (es) Prótesis tubulares
AU2021203915B2 (en) Two-part implantable therapy delivery device
WO2013035957A1 (ko) 생체내 분해기간이 조절 가능한 생체적합성 소장점막하조직 하이드로젤의 제조방법
Shandalov et al. A method for constructing vascularized muscle flap
Acun et al. Liver bioengineering: promise, pitfalls, and hurdles to overcome
US20190001028A1 (en) Techniques for treatment of abscesses
CN104587523A (zh) 一种负载富集骨髓间充质干细胞的自固化磷酸钙骨水泥及制备方法
ES2824752T3 (es) Siembra de población celular en matrices dérmicas para el manejo de trastornos endocrinos
Gill et al. Future perspectives in bladder tissue engineering
JP4067419B2 (ja) 閉鎖型細胞培養システム
KR102671293B1 (ko) 생착 향상을 위한 접착성 이식재
JP2014230685A (ja) 歯周組織形成用材料
WO2023235737A1 (en) Tunnel filler device and methods of use
RU2590859C1 (ru) Способ дистантной стимуляции регенерации гепатоцитов
AU2014200845B2 (en) Methods and Devices for Cellular Transplantation
JPWO2003080143A1 (ja) 脱細胞化組織マトリックス及び細胞成長因子を含む組織又は臓器再建用基材
JP2014534041A (ja) 修飾可能な医療用移植片ならびに関連する方法および機器